Клинички испитувања за ХОБП во Тексас
25 студии за ХОБП бараат учесници на локации во Тексас.
Градови во Тексас
- Houston16 студии
- Dallas13 студии
- McKinney6 студии
- El Paso5 студии
- Mesquite4 студии
- Cypress4 студии
- Grand Prairie3 студии
- Sugar Land3 студии
- Denison3 студии
- The Woodlands3 студии
- San Antonio3 студии
- Lewisville3 студии
Официјален текст на студијата (англиски)
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Austin
- GSK Investigational Site, Dallas
- GSK Investigational Site, El Paso
- и уште 5
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 5.10.2026 · NCT06961214Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
- GSK Investigational Site, Corsicana
- GSK Investigational Site, Dallas
- GSK Investigational Site, Houston
- и уште 4
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 5.10.2026 · NCT06959095A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Abilene
- Research Site, Brownsville
- Research Site, Dallas
- и уште 12
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 2.10.2026 · NCT06283966Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Solace Clinical Research- Site Number : 8400087, Austin
- IntraCare- Site Number : 8400034, Dallas
- Premier Pulmonary Critical Care and Sleep- Site Number : 8400111, Denison
- и уште 7
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 1.10.2026 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Horizon Clinical Research Group., Cypress
- Metroplex Pulmonary and Sleep Center, McKinney
- DM Clinical Research- Tomball, Tomball
Се регрутираФаза 2
Возраст од 40 до 85 · Сите полови · Ажурирано 30.9.2026 · NCT07684820A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Premier Pulmonary Critical Care and Sleep, Denison
- Baylor College of Medicine Medical Center, Houston
- Prime Clinical Research - Lewisville, Lewisville
Се регрутираФаза 2
Возраст од 40 до 75 · Сите полови · Ажурирано 25.9.2026 · NCT07759245A Study of 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis
- Copd01 50001, Boerne
Се регрутираФаза 2
Возраст од 40 до 80 · Сите полови · Ажурирано 25.9.2026 · NCT07725939Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Wellness Clinical Research - Allen- Site Number : 8400085, Allen
- REX Clinical Trials - Beaumont- Site Number : 8400014, Beaumont
- Novel Research - Bellaire- Site Number : 8400116, Bellaire
- и уште 17
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 22.9.2026 · NCT07190209A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- REX Clinical Trials - Beaumont- Site Number : 8400011, Beaumont
Се регрутираФаза 4
Возраст од 40 до 85 · Сите полови · Ажурирано 22.9.2026 · NCT07053423An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- University of Texas Southwestern, Dallas
Се регрутира
Возраст од 40 до 80 · Сите полови · Ажурирано 17.9.2026 · NCT06035120A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, McKinney
- WB Contracted Clinical Research Site, Waxahachie
Се регрутираФаза 2
Возраст од 40 до 80 · Сите полови · Ажурирано 15.9.2026 · NCT07646587A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, Boerne
- Research Site, Dallas
- Research Site, Denison
- и уште 5
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 9.9.2026 · NCT07082738Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
- Baylor College of Medicine, Houston
Се регрутираФаза 2
Возраст 40 и постари · Сите полови · Ажурирано 4.9.2026 · NCT07059091A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, Dallas
- Research Site, Forney
- Research Site, Fort Worth
- и уште 5
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06883305A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Boerne
- Research Site, El Paso
- Research Site, Houston
- и уште 6
Се регрутираФаза 3
Возраст од 40 до 80 · Сите полови · Ажурирано 3.9.2026 · NCT06878261The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- The Lung & Sleep Institute of North Texas, North Richland Hills
Се регрутираНабљудувачка студија
Возраст 40 и постари · Сите полови · Ажурирано 1.9.2026 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- South Texas Medical Research Institute, Inc., DBA TTS Research, Boerne
- Ten20 Clinical Research, Carrollton
- Horizon Clinical Research Group, Cypress
- и уште 4
Се регрутираФаза 2/3
Возраст од 35 до 80 · Сите полови · Ажурирано 31.8.2026 · NCT07363694A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
- GC2501 Study Site 109, Dallas
Се регрутираФаза 3
Возраст од 18 до 80 · Сите полови · Ажурирано 11.8.2026 · NCT07555483STRIVE Post-Market Registry Study
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
- University of Texas Health Science Center at Houston, Houston
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 3.8.2026 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Dallas
- GSK Investigational Site, DeSoto
- GSK Investigational Site, Greenville
- и уште 6
Се регрутираФаза 3
Возраст од 40 до 75 · Сите полови · Ажурирано 28.7.2026 · NCT07177339Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
- Liver Center of Texas, Dallas
- Methodist Hospital, Richardson
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 10.7.2026 · NCT05181826Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Houston Methodist/Primary Critical Care, Houston
Се регрутира
Возраст од 40 до 84 · Сите полови · Ажурирано 24.4.2026 · NCT06891755Interprofessional Pharmacogenomics (IPGx) Registry and Repository
- Texas A&M Family Care, Bryan
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 12.9.2025 · NCT06726590Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Horizon Clinical Research Group, Houston
- CHRISTUS Trinity Mother Frances Health System, Tyler
Се регрутираНабљудувачка студија
Возраст 50 и постари · Сите полови · Ажурирано 5.8.2025 · NCT06122077myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home
- Respire Research Institute, Houston
Се регрутира
Возраст 30 и постари · Сите полови · Ажурирано 6.2.2025 · NCT05204888Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.